Fudan University

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1905-01-01

Employees: 1K

Market Cap: -

Website: http://www.fudan.edu.cn

Clinical Trials

Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma (ECTOP-1002)

Phase 2

Completed

Conditions: Lung Adenocarcinoma

Interventions: Drug: Pemetrexed
Drug: Cisplatin

First Posted Date: 2016-12-02

Last Posted Date: 2023-07-20

Lead Sponsor: Fudan University

Target Recruit Count: 80

Registration Number: NCT02980991

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China

Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer Female

Interventions: Drug: letrozole, leuprorelin, fluorouracil, epirubicin, cyclophosphamide, docetaxel
Drug: fluorouracil, epirubicin, cyclophosphamide, docetaxel

First Posted Date: 2016-12-02

Last Posted Date: 2017-11-13

Lead Sponsor: Fudan University

Target Recruit Count: 249

Registration Number: NCT02980965

Locations: 🇨🇳
Cancer Hospital/ Institute, Fudan University, Shanghai, Shanghai, China

Transanal Tube Drainage in Endoscopic Submucosal Dissection of the Colorectal Tumor

Not Applicable

Conditions: Colorectal Tumor

Interventions: Device: Transanal Tube Drainage

First Posted Date: 2016-11-25

Last Posted Date: 2016-11-25

Lead Sponsor: Fudan University

Target Recruit Count: 1200

Registration Number: NCT02973490

Locations: 🇨🇳
Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China

Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)

Phase 3

Conditions: Locally Advanced Colorectal Cancer

Interventions: Drug: Standard adjuvant systemic chemotherapy
Procedure: Hyperthermic intraperitoneal chemotherapy (HIPEC) with oxaliplatin
Procedure: Hyperthermic intraperitoneal chemotherapy (HIPEC) with raltitrexed

First Posted Date: 2016-11-16

Last Posted Date: 2018-06-19

Lead Sponsor: Fudan University

Target Recruit Count: 147

Registration Number: NCT02965248

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Endoscopic Submucosal Dissection (ESD) and Endoscopic Mucosal Band Ligation (EMBL) for Early Cancer

Conditions: Early Cancer

Interventions: Procedure: endoscopic submucosal dissection (ESD) and endoscopic mucosal band ligation (EMBL) for early cancer

First Posted Date: 2016-11-02

Last Posted Date: 2016-11-02

Lead Sponsor: Fudan University

Target Recruit Count: 50

Registration Number: NCT02952794

Locations: 🇨🇳
Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China

FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients

Phase 3

Conditions: Colorectal Carcinoma

Interventions: Drug: Irinotecan
Drug: 5-fluorouracil
Drug: Leucovorin

First Posted Date: 2016-10-17

Last Posted Date: 2016-10-17

Lead Sponsor: Fudan University

Target Recruit Count: 164

Registration Number: NCT02935764

Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell Carcinoma

Phase 2

Completed

Conditions: Esophageal Squamous Cell Carcinoma

Interventions: Drug: Paclitaxel
Drug: Carboplatin
Radiation: Radiotherapy

First Posted Date: 2016-09-27

Last Posted Date: 2023-12-22

Lead Sponsor: Fudan University

Target Recruit Count: 70

Registration Number: NCT02916511

Locations: 🇨🇳
Fudan Universtiy Shanghai Cancer Center, Shanghai, Shanghai, China

Fulvestrant 500mg in Patients With Advanced Breast Cancer

Conditions: Metastatic Breast Cancer

Interventions: Drug: Fulvestrant

First Posted Date: 2016-09-21

Last Posted Date: 2022-04-20

Lead Sponsor: Fudan University

Target Recruit Count: 500

Registration Number: NCT02909361

Locations: 🇨🇳
Fudan University Cancer Hospital, Shanghai, China

Transanual Tube Placement in Low Anterior Resection (LAR) for Rectal Cancer

Phase 2

Conditions: Rectal Cancer

Interventions: Device: transanual tube placement

First Posted Date: 2016-09-19

Last Posted Date: 2016-09-19

Lead Sponsor: Fudan University

Target Recruit Count: 520

Registration Number: NCT02905968

Locations: 🇨🇳
Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

The Maintenance Treatment of UFT in Advanced Gastric Cancer

Phase 2

Completed

Conditions: Gastric Cancer

Interventions: Drug: UFT

First Posted Date: 2016-09-16

Last Posted Date: 2016-10-12

Lead Sponsor: Fudan University

Target Recruit Count: 58

Registration Number: NCT02903498

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy